https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2019-05-14 08:53:032019-05-14 13:22:24Myovant Sciences’ uterine fibroids combo therapy meets main goal in study